These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 28109674)

  • 41. Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3-5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis.
    Nieuwenhuizen S; Dijkstra M; Puijk RS; Geboers B; Ruarus AH; Schouten EA; Nielsen K; de Vries JJJ; Bruynzeel AME; Scheffer HJ; van den Tol MP; Haasbeek CJA; Meijerink MR
    Curr Oncol Rep; 2022 Jun; 24(6):793-808. PubMed ID: 35298796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of Chronologic Change in the Size and Contrast-Enhancement of Ablation Zones on CT Images after Irreversible Electroporation and Radiofrequency Ablation.
    Scheck J; Bruners P; Schindler D; Kuhl C; Isfort P
    Korean J Radiol; 2018; 19(4):560-567. PubMed ID: 29962862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What's New in Percutaneous Ablative Strategies for Hepatocellular Carcinoma and Colorectal Hepatic Metastases? 2020 Update.
    Arellano RS
    Curr Oncol Rep; 2020 Jul; 22(10):105. PubMed ID: 32725433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Percutaneous ablation therapy of hepatocellular carcinoma with irreversible electroporation: MRI findings.
    Granata V; Fusco R; Catalano O; Piccirillo M; De Bellis M; Izzo F; Petrillo A
    AJR Am J Roentgenol; 2015 May; 204(5):1000-7. PubMed ID: 25905934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recurrent Colorectal Liver Metastases in the Liver Remnant After Major Liver Surgery-IRE as a Salvage Local Treatment When Resection and Thermal Ablation are Unsuitable.
    Hitpass L; Distelmaier M; Neumann UP; Schöning W; Isfort P; Keil S; Kuhl CK; Bruners P; Barabasch A
    Cardiovasc Intervent Radiol; 2022 Feb; 45(2):182-189. PubMed ID: 34757483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
    Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
    Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
    Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
    Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures.
    Cannon R; Ellis S; Hayes D; Narayanan G; Martin RC
    J Surg Oncol; 2013 Apr; 107(5):544-9. PubMed ID: 23090720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preliminary Outcome of Microwave Ablation of Hepatocellular Carcinoma: Breaking the 3-cm Barrier?
    Thamtorawat S; Hicks RM; Yu J; Siripongsakun S; Lin WC; Raman SS; McWilliams JP; Douek M; Bahrami S; Lu DS
    J Vasc Interv Radiol; 2016 May; 27(5):623-30. PubMed ID: 27013403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system.
    Hosein PJ; Echenique A; Loaiza-Bonilla A; Froud T; Barbery K; Rocha Lima CM; Yrizarry JM; Narayanan G
    J Vasc Interv Radiol; 2014 Aug; 25(8):1233-1239.e2. PubMed ID: 24861662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Comparative Study of Ablation Boundary Sharpness After Percutaneous Radiofrequency, Cryo-, Microwave, and Irreversible Electroporation Ablation in Normal Swine Liver and Kidneys.
    Cornelis FH; Durack JC; Kimm SY; Wimmer T; Coleman JA; Solomon SB; Srimathveeravalli G
    Cardiovasc Intervent Radiol; 2017 Oct; 40(10):1600-1608. PubMed ID: 28516273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent.
    Numata K; Fukuda H; Ohto M; Itou R; Nozaki A; Kondou M; Morimoto M; Karasawa E; Tanaka K
    Eur J Radiol; 2010 Aug; 75(2):e67-75. PubMed ID: 20015603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
    Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Major complications of ultrasound-guided percutaneous radiofrequency ablations for liver malignancies: single center experience.
    Chen TM; Huang PT; Lin LF; Tung JN
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e445-50. PubMed ID: 17683478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases.
    Di Martino M; Rompianesi G; Mora-Guzmán I; Martín-Pérez E; Montalti R; Troisi RI
    Eur J Surg Oncol; 2020 May; 46(5):772-781. PubMed ID: 31862133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy.
    Simmerman E; Chung J; Lawson A; Kruse E
    J Surg Res; 2020 Feb; 246():260-268. PubMed ID: 31610354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values.
    Dollinger M; Zeman F; Niessen C; Lang SA; Beyer LP; Müller M; Stroszczynski C; Wiggermann P
    J Vasc Interv Radiol; 2016 Jan; 27(1):96-103. PubMed ID: 26777402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study.
    Buijs M; Zondervan PJ; de Bruin DM; van Lienden KP; Bex A; van Delden OM
    Urol Oncol; 2019 Mar; 37(3):183.e1-183.e8. PubMed ID: 30509869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome.
    Alnaggar M; Lin M; Mesmar A; Liang S; Qaid A; Xu K; Chen J; Niu L; Yin Z
    Cell Physiol Biochem; 2018; 48(5):1882-1893. PubMed ID: 30092590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.